SGTX
Sigilon Therapeutics Inc

866
Loading...
Loading...
Sigilon Therapeutics, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutic treatments for a wide range of chronic diseases. Its program includes Rare Blood Disorders, Lysosomal Storage Diseases, and Endocrine and Other Chronic Diseases. The company was founded by Daniel G. Anderson, Robert S. Langer Jr., Jose Oberholzer, Arturo Vegas, and Omid Veiseh on May 14, 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Sigilon Therapeutics Inc?
What is the 52-week high for Sigilon Therapeutics Inc?
What is the 52-week low for Sigilon Therapeutics Inc?
What is Sigilon Therapeutics Inc stock price today?
What was Sigilon Therapeutics Inc stock price yesterday?
What is the PE ratio of Sigilon Therapeutics Inc?
What is the Price-to-Book ratio of Sigilon Therapeutics Inc?
What is Sigilon Therapeutics Inc's EBITDA?
What is the 50-day moving average of Sigilon Therapeutics Inc?

Latest SGTX News

View
No SGTX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.